Related Experiment Video
Updated: Jun 6, 2026

05:04
Using Simulation Models to Train Clinicians in the Use of Point-of-Care Ultrasound
Published on: August 9, 2024
Patient-level simulation models in cancer care: a systematic review
Sara-Lise Busschaert1, Helena Van Deynse1, Mark De Ridder1
1Department of Public Health, Vrije Universiteit Brussel, Brussels, Belgium.
Frontiers in Public Health
|May 26, 2025
Summary
Patient-level simulation (PLS) models offer advantages in cancer care, modeling disease progression and healthcare delivery. However, reporting quality needs improvement, and direct comparisons with cohort models are necessary.
Area of Science:
- Health economics and outcomes research
- Computational modeling in oncology
- Health services research
Background:
- Patient-level simulation (PLS) models address limitations of traditional cohort models in healthcare.
- Their application in cancer care remains underexplored, necessitating a comprehensive review.
Purpose of the Study:
- To systematically review the application areas of PLS models in cancer care.
- To identify prevalent PLS model structures and assess reporting quality.
- To critically evaluate the potential and limitations of PLS in oncology.
Main Methods:
- Systematic literature search across major databases (Web of Science, PubMed, EMBASE, EconLit).
- Inductive content analysis to identify reasons for PLS model use.
- Reporting quality assessment using an 18-item checklist based on ISPOR-SMDM guidelines.
Main Results:
- Publications on PLS in cancer care are increasing, primarily using state-transition microsimulation or discrete event simulation.
- Key applications include disease progression modeling (DPM) and health and care systems operation (HCSO).
- Average reporting quality was 65.2% and showed no improvement over time.
Conclusions:
- PLS models are valuable for simulating cancer progression and care delivery.
- Further research should compare PLS with cohort models in DPM and assess clinical impact in HCSO.
- Adherence to reporting guidelines like ISPOR-SMDM needs enhancement.
Related Concept Videos
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Methods of Documentation VI: Case Management Model
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic illness...
For example, a patient with a chronic illness...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Actuarial Approach
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
